文献速递神经胸部CTMR

新型重建CT技术能否在初始肺癌分期中挑战MRI对脑转移瘤的检测

Could new reconstruction CT techniques challenge MRI for the detection of brain metastases in the context of initial lung cancer staging?
PubMed 文献 · Eur Radiol · 2017-08-30

前瞻性纳入115例组织学证实肺癌患者,在初始分期时行标准剂量(CTDIvol 41.4 mGy)和半剂量(CTDIvol 20.7 mGy)脑CT,均以FBP和IMR重建,以脑MRI为参考。标准剂量IMR与半剂量FBP间无显著差异(p=0.12),各CT技术特异度98.9-100%。结论认为脑MRI仍是肺癌分期的最佳工具。

要点

  • 标准剂量IMR与半剂量FBP检出脑转移瘤无显著差异(p=0.12)。
  • 与FBP相比,IMR提高图像质量且不损害诊断效能。
  • 联合IMR重建可实现50%剂量降低。

核心结论

  • 两种CT重建技术间未显示显著差异,脑MRI仍是肺癌分期的最佳工具。

研究设计与样本

  • 前瞻性研究,15个月内纳入115例组织学证实肺癌患者,最终93例完成所有检查;采用256层MDCT行标准剂量(CTDIvol 41.4 mGy)和半剂量(CTDIvol 20.7 mGy)两次采集,均以FBP和IMR重建,以脑MRI为参考标准,两名盲法独立阅片者分析。

关键影像表现/征象

  • 标准剂量下,IMR和FBP CT图像上分别有8例患者显示17个和15个病灶。
  • 半剂量下,IMR和FBP CT图像上分别有7例患者显示15个和13个病灶。
  • MRI在11例患者中显示46个转移灶。

诊断标准与关键数值

  • 所有CT技术的特异度为98.9-100%,阴性预测值为93.6-94.6%,阳性预测值为75-100%。
  • 标准剂量IMR与半剂量FBP技术间无显著差异(p=0.12)。

临床应用与阅片要点

  • 脑MRI仍是肺癌分期检测脑转移瘤的最佳工具。
  • 与FBP相比,IMR提高图像质量且无诊断损害。
  • 联合IMR重建可实现50%剂量降低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the diagnostic performance of brain CT images reconstructed with a model-based iterative algorithm performed at usual and reduced dose.

METHODS: 115 patients with histologically proven lung cancer were prospectively included over 15 months. Patients underwent two CT acquisitions at the initial staging, performed on a 256-slice MDCT, at standard (CTDIvol: 41.4 mGy) and half dose (CTDIvol: 20.7 mGy). Both image datasets were reconstructed with filtered back projection (FBP) and iterative model-based reconstruction (IMR) algorithms. Brain MRI was considered as the reference. Two blinded independent readers analysed the images.

RESULTS: Ninety-three patients underwent all examinations. At the standard dose, eight patients presented 17 and 15 lesions on IMR and FBP CT images, respectively. At half-dose, seven patients presented 15 and 13 lesions on IMR and FBP CT images, respectively. The test could not highlight any significant difference between the standard dose IMR and the half-dose FBP techniques (p-value = 0.12). MRI showed 46 metastases on 11 patients. Specificity, negative and positive predictive values were calculated (98.9-100 %, 93.6-94.6 %, 75-100 %, respectively, for all CT techniques).

CONCLUSION: No significant difference could be demonstrated between the two CT reconstruction techniques.

KEY POINTS: • No significant difference between IMR100 and FBP50 was shown. • Compared to FBP, IMR increased the image quality without diagnostic impairment. • A 50 % dose reduction combined with IMR reconstructions could be achieved. • Brain MRI remains the best tool in lung cancer staging.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Millon D, Byl D, Collard P, et al. Could new reconstruction CT techniques challenge MRI for the detection of brain metastases in the context of initial lung cancer staging? Eur Radiol. 2017. PMID: 28856413. doi:10.1007/s00330-017-5021-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。